PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för garenoxacin. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

11 hits

Bibliografisk träff 2015-10-30

Analysis of garenoxacin distribution in the mediastinum using endobronchial ultrasound-guided transbronchial needle aspiration.

Endo S, Sasaki T, Onishi K, Kazebayashi Y, Hirai N, Minami Y, Toyoshima E, Yamamoto Y, Kishino S, Ohsaki Y.

Int J Antimicrob Agents · letter · DOI 10.1016/j.ijantimicag.2015.10.001

Bibliografisk träff 2015-06-01

Pharmacokinetic study of garenoxacin in severe renal failure patients.

Yamagishi Y, Hagihara M, Hamada Y, Kimura Y, Imai H, Mikamo H.

Jpn J Antibiot · randomized controlled trial; journal article

Bibliografisk träff 2015-05-19

Comparison of garenoxacin with levofloxacin as antimicrobial prophylaxis in acute myeloid leukemia.

Uni M, Yoshimi A, Yamazaki S, Taoka K, Shinohara A, Nannya Y, Nakamura F, Kurokawa M.

Jpn J Clin Oncol · comparative study; journal article · DOI 10.1093/jjco/hyv071

Bibliografisk träff 2015-05-01

A prescription event monitoring study on the utility of garenoxacin, a newer fluoroquinolone in India.

Hajare A, Gupta A, Patil S, Krishnaprasad K, Bhargava A.

Int J Appl Basic Med Res · research-article; journal article · DOI 10.4103/2229-516x.157151

Bibliografisk träff 2014-01-01

Garenoxacin.

Vora A.

J Assoc Physicians India · journal article

Bibliografisk träff 2011-11-15

In vitro pharmacodynamic evaluation of garenoxacin against quinolone-resistant Streptococcus pneumoniae.

Fukuda Y, Takahata M, Sugiura Y, Shinmura Y, Nomura N.

Int J Antimicrob Agents · comparative study; journal article · DOI 10.1016/j.ijantimicag.2011.09.021

Bibliografisk träff 2011-07-28

Optimal dose finding of garenoxacin based on population pharmacokinetics/pharmacodynamics and Monte Carlo simulation.

Tanigawara Y, Nozawa K, Tsuda H.

Eur J Clin Pharmacol · clinical trial, phase iii; clinical trial, phase ii; research-article; validation study; clinical trial, phase i; journal article · DOI 10.1007/s00228-011-1095-3

Bibliografisk träff 2011-07-08

Anti-inflammatory effects of garenoxacin on IL-8 production and ERK1/2 activation induced by lipopolysaccharides in A549 and THP-1 cells.

Hara S, Ishimatsu Y, Mukae H, Sakamoto N, Kakugawa T, Fujita H, Hara A, Kohno S.

Eur J Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ejphar.2011.06.046

Bibliografisk träff 2002-01-01

Synthesis, antibacterial activity, and toxicity of 7-(isoindolin-5-yl)-4-oxoquinoline-3-carboxylic acids. Discovery of the novel des-F(6)-quinolone antibacterial agent garenoxacin (T-3811 or BMS-284756).

Hayashi K, Takahata M, Kawamura Y, Todo Y.

Arzneimittelforschung · journal article · DOI 10.1055/s-0031-1299988

Bibliografisk träff 2001-12-01

T-3811. Toyama/Bristol-Myers Squibb.

Frechette R.

Curr Opin Investig Drugs · review; journal article

Bibliografisk träff 2001-11-01

Antimicrobial activity of BMS 284756 (T-3811) against Neisseria gonorrhoeae tested by three methods.

Deshpande L, Biedenbach DJ, Jones RN.

Int J Antimicrob Agents · journal article · DOI 10.1016/s0924-8579(01)00438-1